A Randomized, Double-blind, Controlled Trial of Tranexamic Acid in Pediatric Epilepsy Surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17014033

Enrollment

Unknown

Registered

2017-12-19

Start date

2017-12-20

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Epilepsy

Interventions

T Group:use tranexamic acid during surgery

C Group:use placebo during surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Symptomatic epilepsy patients; 2. Aged 1-12 years old 3. Weight=40Kg; 4. ASA physical status I~II.

Exclusion criteria

Exclusion criteria: 1. Hepatic and renal functions abnormality; 2. Blood system diseases; 3. Family history of hemorrhagic disease; 4. Secondary craniotomy for epilepsy surgery; 5. Allergy to tranexamic acid; 6 .Refuse to participate in the research.

Design outcomes

Primary

Measure	Time frame
Blood coagulation substances infusion rate;Proportion of patients who were transfused with allogeneic blood;	—

Secondary

Measure	Time frame
Average amounts of blood loss;Complications related to allogeneic blood transfusion;Postoperative thromboembolic events;	—

Countries

China

Contacts

Public ContactWang Tianlong

Department of Anesthesiology and Operating Theatre, Xuanwu Hospital of Capital Medical University

w_tl5595@hotmail.com+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026